register

News & Trends - Pharmaceuticals

Fresenius Kabi gains TGA approval for new biosimilar

Health Industry Hub | June 29, 2020 |

Pharma News: Fresenius Kabi secured TGA registration of Idacio, a biosimilar medicine to AbbVie’s Humira (adalimumab).

With global sales of US$20 billion in 2018, AbbVie’s Humira has been a target for a number of biosimilars.

The drug is an antibody treatment for a range of inflammatory conditions, including various forms of arthritis, inflammatory bowel disease and psoriasis.

Fresenius Kabi’s Idacio (adalimumab rch) is approved for:

  • Rheumatoid arthritis as monotherapy or in combination with methotrexate
  • Juvenile idiopathic arthritis – in combination with methotrexate is indicated for reducing the signs and symptoms of moderately to severely active polyarticular juvenile idiopathic arthritis
  • Psoriatic arthritis – moderate to severe disease
  • Ankylosing spondylitis
  • Crohn’s disease in adults and children (≥ 6 years)
  • Ulcerative colitis – moderate to severe disease
  • Psoriasis in adults and children – active moderate to severe hidradenitis suppuratives (acne inversa)
  • Uveitis – non-infectious intermediate, posterior and pan-uveitis

Other adalimumab biosimilars registered in Australia include Amgen’s Amgevita since 2017, Samsung Bioepis’ Hadlima since 2018 and Sandoz’s Hyrimoz since 2019.


News & Trends - MedTech & Diagnostics

Parliament passes lung cancer legislation

Parliament passes lung cancer legislation

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Lung cancer is the leading cause of cancer death and is responsible for almost one in […]

More


News & Trends - Pharmaceuticals

Senator Ruston criticises Budget's lack of 'real seamanship' in tackling pressing healthcare challenges

Senator Ruston criticises Budget’s lack of ‘real seamanship’ in tackling pressing healthcare challenges

Health Industry Hub | May 17, 2024 |

Pharma News: Senator Anne Ruston, Shadow Health Minister, was warmly welcomed at the Post-Budget event held in Parliament House yesterday […]

More


News & Trends - MedTech & Diagnostics

Baxter announces branding for spin-off kidney care business

Baxter announces branding for spin-off kidney care business

Health Industry Hub | May 17, 2024 |

MedTech & Diagnostics News: Baxter has unveiled the mission and logo for its forthcoming kidney care and acute therapies company, […]

More


ESG

Health and climate strategy: All talk, no budget

Health and climate strategy: All talk, no budget

Health Industry Hub | May 16, 2024 |

ESG: The Federal Budget has sparked disappointment among health professionals for its lack of attention to addressing the escalating impacts […]

More


This content is copyright protected. Please subscribe to gain access.